WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 510276
Description: BMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS-303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model.
MedKoo Cat#: 510276
Chemical Formula: C19H15Cl2NO4S
Exact Mass: 423.00988
Molecular Weight: 424.2977
Elemental Analysis: C, 53.78; H, 3.56; Cl, 16.71; N, 3.30; O, 15.08; S, 7.56
BMS-303141, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.
Synonym: BMS303141; BMS-303141; BMS 303141.
IUPAC/Chemical Name: 3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1′-biphenyl]-3-yl)-benzenesulfonamide
InChi Key: SIIPNDKXZOTLEA-UHFFFAOYSA-N
InChi Code: InChI=1S/C19H15Cl2NO4S/c1-26-17-8-7-13(12-5-3-2-4-6-12)9-16(17)22-27(24,25)18-11-14(20)10-15(21)19(18)23/h2-11,22-23H,1H3
SMILES Code: O=S(C1=CC(Cl)=CC(Cl)=C1O)(NC2=CC(C3=CC=CC=C3)=CC=C2OC)=O
The following data is based on the product molecular weight 424.2977 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|